Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-22

FDA Approved: CORTROSYN — Supplemental Application (Amphastar Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Cortrosyn (cosyntropin) from Amphastar Pharmaceuticals, Inc., authorizing changes to the approved product under …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CORTROSYN (cosyntropin)

Snippet

SUPPL AP for CORTROSYN (COSYNTROPIN)